Painful peripheral neuropathies.

[1]  W. Litchy,et al.  Subacute diabetic proximal neuropathy. , 1997, Mayo Clinic proceedings.

[2]  M. Pfeifer,et al.  Aldose Reductase Inhibitors: The End of an Era or the Need for Different Trial Designs? , 1997, Diabetes.

[3]  P. Fernyhough,et al.  Role of Neurotrophins in Diabetic Neuropathy and Treatment with Nerve Growth Factors , 1997, Diabetes.

[4]  P. Thomas,et al.  Classification, Differential Diagnosis, and Staging of Diabetic Peripheral Neuropathy , 1997, Diabetes.

[5]  E. Favale,et al.  Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia , 1997, Neurology.

[6]  M. Max,et al.  High‐dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia , 1997, Neurology.

[7]  C. Pozzilli,et al.  Pain in Guillain-Barré syndrome , 1997, Neurology.

[8]  P. Dyck,et al.  Pathologic Alterations in the Diabetic Neuropathies of Humans: A Review , 1996, Journal of neuropathology and experimental neurology.

[9]  T. Yaksh,et al.  Concurrent Spinal Infusion of MK801 Blocks Spinal Tolerance and Dependence Induced by Chronic Intrathecal Morphine in the Rat , 1996, Anesthesiology.

[10]  G. Rordorf,et al.  Gabapentin as a novel treatment for postherpetic neuralgia , 1996, Neurology.

[11]  M. Rowbotham,et al.  Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia , 1996, Pain.

[12]  G. Benedittis,et al.  Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study , 1996, Pain.

[13]  H. Tritschler,et al.  Lipoic Acid Improves Nerve Blood Flow, Reduces Oxidative Stress, and Improves Distal Nerve Conduction in Experimental Diabetic Neuropathy , 1995, Diabetes Care.

[14]  E. Araki,et al.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.

[15]  M. Byas-Smith,et al.  Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ design , 1995, Pain.

[16]  P. Fernyhough,et al.  Diabetic neuropathy, nerve growth factor and other neurotrophic factors , 1994, Trends in Neurosciences.

[17]  R. Levy,et al.  Consensus conference on the neurosurgical management of pain. , 1994, Neurosurgery.

[18]  R. Dotson.  Causalgia—reflex sympathetic dystrophy—sympathetically maintained pain: Myth and reality , 1993, Muscle & nerve.

[19]  K. Tyler,et al.  A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. , 1993, Clinical therapeutics.

[20]  W. J. Litchy,et al.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.

[21]  Ronald Melzack,et al.  Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence , 1993, Pain.

[22]  R Dubner,et al.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. , 1992, The New England journal of medicine.

[23]  E. Chaney,et al.  The use of oral mexiletine for the treatment of pain after peripheral nerve injury. , 1992, Anesthesiology.

[24]  G. Pasternak,et al.  Individual variability in the response to different opioids: report of five cases , 1992, Pain.

[25]  R. Tandan,et al.  Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up , 1992, Diabetes Care.

[26]  S. McMahon,et al.  Mechanisms of sympathetic pain. , 1991, British medical bulletin.

[27]  M. Rowbotham,et al.  Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia , 1991, Neurology.

[28]  G. Bennett.  The role of the sympathetic nervous system in painful peripheral neuropathy , 1991, PAIN.

[29]  D. Tarsy,et al.  Does capsaicin relieve the pain of diabetic neuropathy? , 1990, Pain.

[30]  K. Brøsen,et al.  The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms , 1990, Pain.

[31]  R. Dubner,et al.  Association of pain relief with drug side effects in postherpetic neuralgia: A single‐dose study of clonidine, codeine, ibuprofen, and placebo , 1988, Clinical pharmacology and therapeutics.

[32]  B. Meyerson,et al.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain , 1988, Pain.

[33]  J. Kastrup,et al.  MEXILETINE FOR TREATMENT OF CHRONIC PAINFUL DIABETIC NEUROPATHY , 1988, The Lancet.

[34]  Patrick D. Wall,et al.  Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input , 1987, Nature.

[35]  J. Croese,et al.  Clonidine and diabetic patients with leg pains. , 1986, Annals of internal medicine.

[36]  Russell K. Portenoy,et al.  Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases , 1986, Pain.

[37]  J. Ewing,et al.  Detecting alcoholism. The CAGE questionnaire. , 1984, JAMA.

[38]  D. Machin,et al.  Acupuncture compared with placebo in post-herpetic pain , 1983, Pain.

[39]  J. B. Peiris,et al.  SODIUM VALPROATE IN TRIGEMINAL NEURALGIA , 1980, The Medical journal of Australia.

[40]  H. Raftery.  The management of post herpetic pain using sodium valproate and amitriptyline. , 1979, Irish medical journal.

[41]  G. Cole.  Management Theory and Practice , 1979 .

[42]  P. Pickerill.  A NEW METHOD OF OSTEOPLASTIC RESTORATION OF THE SKULL , 1931 .

[43]  L. Mellick,et al.  Reflex sympathetic dystrophy treated with gabapentin. , 1997, Archives of physical medicine and rehabilitation.

[44]  J. Levine,et al.  Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. , 1996, Progress in brain research.

[45]  R. Portenoy,et al.  Pain management : theory and practice , 1996 .

[46]  M. Zimmermann,et al.  Chapter 18 Plasticity of the nervous system at the systemic, cellular and molecular levels: a mechanism of chronic pain and hyperalgesia , 1996 .

[47]  K. McPherson,et al.  Oestrogens and breast cancer: exogenous hormones. , 1991, British medical bulletin.

[48]  M. Caccia.  Clonazepam in Facial Neuralgia and Cluster Headache , 1975 .